Analyst
Azuho
Equibles does not estimate personal net worth.
Anthony Petron is recorded as Analyst at Azuho. Anthony Petron has spoken on 4 investor events across 1 company, most recently for Edap Tms SA on September 15, 2026. The companies whose calls Anthony Petron spoke on are classified in the Healthcare sector.
“Great analyst meeting, and thanks for the presentation from Dr. Day as well as the guidance. Maybe to start with the percentage of low-volume, high-risk prostate cases that Dr. Day highlighted, how many of those can actually transition into focal one therapies when you think of leveraging MRI biopsy?”
“Great analyst meeting, and thanks for the presentation from Dr. Day as well as the guidance. Maybe to start with the percentage of low-volume, high-risk prostate cases that Dr. Day highlighted, how many of those can actually transition into focal one therapies when you think of leveraging MRI biopsy?”
“Great analyst meeting, and thanks for the presentation from Dr. Day as well as the guidance. Maybe to start with the percentage of low-volume, high-risk prostate cases that Dr. Day highlighted, how many of those can actually transition into focal one therapies when you think of leveraging MRI biopsy?”
“Great analyst meeting, and thanks for the presentation from Dr. Day as well as the guidance. Maybe to start with the percentage of low-volume, high-risk prostate cases that Dr. Day highlighted, how many of those can actually transition into focal one therapies when you think of leveraging MRI biopsy?”
Azuho
Analyst
Transcript header (unverified)
FOCL
Medical Distribution · Healthcare
